网上购物 货比三家
您现在的位置:快乐比价网 > 图书 > 教育/科技 > 原版书与影印版 > 商品详情

凯利风湿病学(英文原版)(1.2)

分享到:
凯利风湿病学(英文原版)(1.2)

最 低 价:¥255.00

定 价:¥0.00

作 者:(美)路迪 著

出 版 社:人民卫生出版社

出版时间:2002-8-1

I S B N:9787117049962

价格
缺货
  • 凯利风湿病学
  • 送货上门
  • 价格
    255.00元
    价格
    382.50元
  • 凯利风湿病学
  • 送货上门
  • 价格
    402.90元

    商品详情

    编辑推荐

    内容简介

    More than 20 years ago, in the preface to the first edition of the Textbook of Rheumatology, we suggested that "The field of rheumatology has come of age." What we meant was that rheumatology had shed its strictly empirical base and its host of unproven remedies and become a healing discipline thoroughly grounded in science. We thought it was time for a new textbook, one that reflected this passage through epistemological puberty.
    The sixth edition reflects the maturation of rheumatology as a subspecialty. It is instructive to compare the contents of the first and sixth editions. Many chapters have disappeared entirely, and their material has been condensed and incorporated into existing chapters. Consider, for example, that in the basic science section of the first edition we devoted entire chapters to immunoglobulin structure, the contact activation system, and lysosomes (not to mention purine metabolism, a subject dear to the heart of the then senior editor). Cyclic nucleotides and eosinophilic chemotactic factor of anaphylaxis figured prominently in the titles of other basic science chapters. None of these has a place in the Table of Contents of the current edition. Instead, there are chapters dealing with dendritic cells, leukotrienes, mast cells, nitric oxide, fibroblasts, cytokines, and apoptosis. The importance of these topics to understanding the rheumatic diseases was unknown 20 years ago, and some of them hadn't even been discovered! Who can imagine what the scientific basis of rheumatology will be in the 10th edition, 20 years from now? Surely, knowledge obtained from the working through of the human genome will figure prominently.

    作者简介

    目录

    VOLUME 1
    Section 1 BIOLOGY OF THE NORMAL JOINT
    1. BIOLOGY OF THE NORMAL JOINT
    2. COLLAGEN AND ELASTIN
    3. MATRIX GLYCOPROTEINS,PROTEOGLYCANS,AND CARTILAGE
    4. PROTEINASES AND MATRIX DEGRADATION
    5. BIOMECHANICS OF JOINTS
    Section 2 IMMUNE AND INFLAMMATORY RESPONSES
    6. MACROPHAGES,DENDRITIC CELLS,AND FOLLICULAR DENDRITIC CELLS
    7. GENETICS OF RHEUMATIC DISEASES
    8. T LYMPHOCYTES
    9. B CELLS
    10. RHEUMATOID FACTOR
    11. ANTINUCLEAR ANTIBODIES
    12. IMMUNE COMPLEXES
    13. COMPLEMENT
    14. NEUTROPHILS AND EOSINOPHILS
    15. PROSTAGLANDINS,LEUKOTRIENES,AND RELATED COMPOUNDS
    16. THE MAST CELL
    17. ENDOTHELIAL CELLS AND NITRIC OXIDE
    18. PLATELETS
    19. FIBROBLAST FUNCTION AND FIBROSIS
    20. CYTOKINES
    21. APOPTOSIS
    22. AUTOMMUNITY
    Section 3 EVALUATION OF THE PATIENT
    23. EPIDEMIOLOGY OF THE RHEUMATIC DISEASES
    24. EVIDENCE-BASED RHEUMATOLOGY
    25. EXAMINATION OF THE JOINTS
    26. MONARTICULAR ARTHRITIS
    27. POLYARTICULAR ARTHRITIS
    28. WEAKNESS
    29. THE EYE AND RHEUMATIC DISEASE
    30. THE SKIN
    Section 4 MUSCULOSKELETAL PAIN AND EVALUATION
    31. FIBROMYALGIA
    32. OCCUPATIONAL AND RECREATIONAL MUSCULOSKELETAL DISORDERS
    33. SPORTS MEDICINE
    34. NECK PAIN
    35. SHOULDER PAIN
    36. LOW BACK PAIN
    37. HIP AND KNEE PAIN
    38. ANKLE AND FOOT PAIN
    39. TEMPOROMANDIBULAR JOINT PAIN
    40. HAND AND WRIST PAIN
    Section 5 DIAGNOSTIC TESTS AND PROCEDURES
    41. ASPIRATION AND INJECTION OF JOINTS AND SOFT TISSUES
    42. SYNOVIAL FLUID ANALYSIS AND SYNOVIAL BIOPSY
    43. IMAGING
    44. ARTHROSCOPY AND SYNOVECTOMY
    45. LABORATORY EVALUATION OF INFLAMMATION
    46. BIOLOGIC MARKERS
    Section 6 SPECIAL ISSUES
    47. NUTRITION AND RHEUMATIC DISEASES
    48. PSYCHOSOCIAL MANAGEMENT OF RHEUMATIC DISEASES
    49. GERIATRICS AND THE RHEUMATIC DISEASES
    50. ALTERNATIVE CARE FOR ARTHRITIS AND RELATED MUSCULOSKELETAL DISEASES
    51. CHRONIC PAIN MANAGEMENT
    52. REHABILITATION OF PATIENTS WITH RHEUMATIC DISEASES
    53. HEALTH OUTCOME ASSESSMENT
    Section 7 CLINICAL PHARMACOLOGY
    54. DEVELOPING A CLINICAL TRIAL DESIGN
    55. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    56. GLUCOCORTICOIDS
    57. METHOTREXATE
    58. SULFASALAZINE
    59. ANTIMALARIAL DRUGS
    60. GOLD AND PENICILLAMINE
    61. IMMUNOREGULATORY DRUGS
    62. BIOLOGIC AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    63. TETRACYCLINES
    INDEX
    VOLUME 2
    Section 8 RHEUMATOID ARTHRITIS
    Section 9 SPONDYLOARTHROPATHIES
    Section 10 SYSTEMIC LUPUS ERYTHEMATOSUS AND RELATED SYNDROMES
    Section 11 VASCULITIC SYNDROMES
    Section 12 SCLERODERMA AND MIXED CONNECTIVE TISSUE DISEASES
    Section 13 STRUCTURE,FUNCTION,AND DISEASE OF MUSCLE
    Section 14 RHEUMATIC DISEASES OF CHILDHOOD
    Section 15 CRYSTAL-ASSOCIATED SYNOVITIS
    Section 16 OSTEOARTHRITIS,POLYCHONDRITIS,AND HERITABLE DISORDERS
    Section 17 ARTHRITIS RELATED TO INFECTION
    Section 18 ARTHRITIS ACCOMPANYING SYSTEMIC DISORDERS
    Section 19 DISORDERS OF BONE AND STRUCTURAL PROTEIN
    Section 20 TUMORS INVOLVING JOINTS
    Section 21 RECONSTRUCTIVE SURGERY FOR RHEUMATIC DISEASE
    INDEX

    商品评论(0条)

    暂无评论!

    您的浏览历史

    loading 内容加载中,请稍后...